Licensing Long-Term Care Facilities Nurses 
The Pharma Data
JANUARY 24, 2021
National Institute of Allergy and Infectious Diseases (NIAID), of bamlanivimab (LY-CoV555) decreased the risk of COVID-19 among residents and staff of long-term care facilities, i.e., nursing homes. The drug was licensed from Immutep Limited.
The Pharma Data
JANUARY 26, 2021
Lilly has received feedback from front-line nurses and doctors administering these infusions regarding the complexity and time requirements for preparation and administration. It remains under review by the FDA. A Phase 2/3 study in people recently diagnosed with COVID-19 in the ambulatory setting (BLAZE-1, NCT04427501) is ongoing.
Expert insights. Personalized for you.
52 
Let's personalize your content